Related Experiment Video
Updated: Jun 23, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century
Jennifer L Lee1, Stanley M Naguwa, Gurtej S Cheema
1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Suite 6510, Davis, CA 95616, USA.
Insights
Acute rheumatic fever (ARF) is an autoimmune disease following strep throat, primarily affecting children in developing nations. Rheumatic heart disease (RHD) is a major complication, but GAS vaccines may offer future prevention.
Area of Science:
- Immunology
- Infectious Diseases
- Pediatrics
Background:
- Acute rheumatic fever (ARF) is an autoimmune sequela of group A Streptococcus (GAS) pharyngitis.
- It disproportionately affects pediatric populations in developing countries.
Observation:
- The primary cause of morbidity and mortality is rheumatic heart disease (RHD).
- Cardinal symptoms include polyarthritis, Sydenham's chorea, subcutaneous nodules, and erythema marginatum.
Findings:
- Current therapy targets GAS infection, acute symptoms with anti-inflammatories, and RHD with surgery.
- Long-term antibiotic prophylaxis is essential for secondary prevention due to high recurrence rates.
Implications:
- GAS vaccination is a promising future strategy for primary and secondary prevention of ARF and RHD.
- Vaccination could significantly reduce the burden of ARF and RHD in vulnerable populations.
Abstract:
Acute rheumatic fever (ARF) is an autoimmune, multi-system response secondary to molecular mimicry following Lancefield group A streptococcus (GAS) pharyngitis; it is now most commonly found in the pediatric populations of developing nations. The major source of morbidity and mortality of ARF stems from rheumatic heart disease (RHD), although the cardinal symptoms of the disease also include polyarthritis, Sydenham's chorea, subcutaneous nodules, and erythema marginatum. Therapy is aimed towards treating the initial GAS infection, using anti-inflammatory medications for acute symptoms and surgery to correct RHD. Secondary prevention is crucial, given the high risk of recurrence, and includes long-term antibiotic prophylaxis. However, vaccination towards GAS may soon be on the horizon, which may assist in both decreasing the risk of initial infection in naïve patients and helping to lower the risk of recurrence.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Streptococcal Pharyngitis
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.